drugset / Trial / NCT02603770

Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers

NCT02603770

Phase 1 Completed 20 enrolled Luye Pharma Group Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to compare laboratory tests profiles of a botanic drug XueZhiKang (XZK) 300 mg capsules versus a marketed drug Lovastatin 20 mg tablets in healthy male volunteers between 18 and 50 years of age.

Timeline

Start
2015-11
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovastatin Small molecule 20 mg
Subject Xuezhikang Traditional medicine (herbal / TCM) 1200 mg